Abstract Library

#4371 Clinical management of oesophageal NEC: A popular based study

Introduction: The clinical research of neuroendocrine carcinoma (NEC) in oesophagus are limited.

Conference:

Presenting Author:

Authors: Cai W, Zhang J, Ge W, Hu H,

Keywords: neuroendocrine carcinoma, oesophagus, clinical practice, survival,

#4215 Breast neuroendocrine carcinomas surgery: A case report

Introduction: Breast carcinoma with neuroendocrine differentiation, also known as breast carcinoma (NEBC), (1) includes a heterogeneous group of rare tumors, which account for 2–5% of (2.3) all invasive breast carcinomas, less than 1% of neuroendocrine tumors. Large cell carcinoma of the breast represente < 0.1% of primary breast cancers; rarer than small cell carcinoma. Occur mainly in the 6th decade (2).

Conference:

Presenting Author:

Authors: Bennaoum S, Kaid M,

Keywords: Surgery, breast neuroendocrine,

#3913 Clinicopathological characteristics and survival of head and neck neuroendocrine carcinoma

Introduction: Neuroendocrine carcinoma (NEC) of head and neck including epidemiology, primary site, treatment, and prognosis remains sparse.

Conference:

Presenting Author: Cai W

Authors: Cai W, Ge W, Zhang J, Yuan Y, Hu H,

Keywords: Neuroendocrine carcinoma, Head and neck,

#3702 The role of the somatostatin analogues in large cell neuroendocrine carcinomas treatment

Introduction: Large cell neuroendocrine carcinoma (LCNEC) is still a poorly studied disease with low somatostatin receptors expression, so we have scant data on the effectiveness of the somatostatin analogues (SSA) in this disease.

Conference:

Presenting Author: Evdokimova E

Authors: Evdokimova E, Artamonova E, Delektorskaya V, Yemelyanova G, Markovich A,

Keywords: NEC, SSTR, somatostatin analogues, large cell carcinoma, SSA, LCNEC, somatostatin receptor,

#3435 Comparative characteristics of TTF-1 and SOX2 expression in neuroendocrine tumors of the lungs and thymus

Introduction: Neuroendocrine tumors of the lungs (NETLs) and thymus (NETTs) are a heterogeneous group of tumors. SOX2 is a key regulator of pluripotency induction, which is also involved in the mechanisms of carcinogenesis.

Conference:

Presenting Author:

Authors: Gurevich L, Bondarenko E,

Keywords: TTF-1, SOX-2, neuroendocrine tumor, lung, thymus,